TY - JOUR
T1 - Non-coding RNAs and exosomal non-coding RNAs in pituitary adenoma
AU - Rahimian, Neda
AU - Sheida, Amirhossein
AU - Rajabi, Mohammadreza
AU - Heidari, Mohammad Mahdi
AU - Tobeiha, Mohammad
AU - Esfahani, Pegah Veradi
AU - Ahmadi Asouri, Sahar
AU - Hamblin, Michael R.
AU - Mohamadzadeh, Omid
AU - Motamedzadeh, Alireza
AU - Khaksary Mahabady, Mahmood
N1 - Publisher Copyright:
© 2023 Elsevier GmbH
PY - 2023/8
Y1 - 2023/8
N2 - Pituitary adenoma (PA) is the third most common primary intracranial tumor in terms of overall disease incidence. Although they are benign tumors, they can have a variety of clinical symptoms, but are mostly asymptomatic, which often leads to diagnosis at an advanced stage when surgical intervention is ineffective. Earlier identification of PA could reduce morbidity and allow better clinical management of the affected patients. Non-coding RNAs (ncRNAs) do not generally code for proteins, but can modulate biological processes at the post-transcriptional level through a variety of molecular mechanisms. An increased number of ncRNA expression profiles have been found in PAs. Therefore, understanding the expression patterns of different ncRNAs could be a promising method for developing non-invasive biomarkers. This review summarizes the expression patterns of dysregulated ncRNAs (microRNAs, long non-coding RNAs, and circular RNAs) involved in PA, which could one day serve as innovative biomarkers or therapeutic targets for the treatment of this neoplasia. We also discuss the potential molecular pathways by which the dysregulated ncRNAs could cause PA and affect its progression.
AB - Pituitary adenoma (PA) is the third most common primary intracranial tumor in terms of overall disease incidence. Although they are benign tumors, they can have a variety of clinical symptoms, but are mostly asymptomatic, which often leads to diagnosis at an advanced stage when surgical intervention is ineffective. Earlier identification of PA could reduce morbidity and allow better clinical management of the affected patients. Non-coding RNAs (ncRNAs) do not generally code for proteins, but can modulate biological processes at the post-transcriptional level through a variety of molecular mechanisms. An increased number of ncRNA expression profiles have been found in PAs. Therefore, understanding the expression patterns of different ncRNAs could be a promising method for developing non-invasive biomarkers. This review summarizes the expression patterns of dysregulated ncRNAs (microRNAs, long non-coding RNAs, and circular RNAs) involved in PA, which could one day serve as innovative biomarkers or therapeutic targets for the treatment of this neoplasia. We also discuss the potential molecular pathways by which the dysregulated ncRNAs could cause PA and affect its progression.
KW - Circular RNAs
KW - Exosomes
KW - Long non-coding RNAs
KW - MicroRNAs
KW - Non-coding RNAs
KW - Pituitary adenomas
UR - http://www.scopus.com/inward/record.url?scp=85165029321&partnerID=8YFLogxK
U2 - 10.1016/j.prp.2023.154649
DO - 10.1016/j.prp.2023.154649
M3 - Review article
C2 - 37453360
AN - SCOPUS:85165029321
SN - 0344-0338
VL - 248
JO - Pathology Research and Practice
JF - Pathology Research and Practice
M1 - 154649
ER -